HOB BIOTECH GROUP CORP.,LTD. — Investor Relations & Filings
About HOB BIOTECH GROUP CORP.,LTD.
HOB Biotech Group Corp., Ltd. specializes in the development, manufacture, and distribution of in vitro diagnostic (IVD) products, with a primary focus on allergy and autoimmune disease testing. The company provides a comprehensive range of diagnostic solutions, including enzyme-linked immunosorbent assays (ELISA), line immunoassays, and advanced chemiluminescence immunoassay (CLIA) systems. Its product portfolio covers hundreds of allergens and a wide array of autoimmune markers, catering to clinical laboratories and healthcare providers. HOB Biotech is recognized for its proprietary technology platforms that enable high-throughput, automated testing, improving diagnostic efficiency and accuracy. The company's commitment to research and development supports the continuous expansion of its diagnostic menu to address evolving clinical needs in immunology and hypersensitivity.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 江苏浩欧博生物医药股份有限公司关于召开2025年第四次临时股东大会的通知 | 2025-10-29 | Chinese | |
| 江苏浩欧博生物医药股份有限公司董事会提名委员会关于第三届董事会职工代表董事候选人任职资格的审查意见 | 2025-10-29 | Chinese | |
| 江苏浩欧博生物医药股份有限公司会计师事务所选聘制度 | 2025-10-29 | Chinese | |
| 江苏浩欧博生物医药股份有限公司累积投票制实施细则 | 2025-10-29 | Chinese | |
| 江苏浩欧博生物医药股份有限公司独立董事工作细则 | 2025-10-29 | Chinese | |
| 江苏浩欧博生物医药股份有限公司对外投资与资产处置管理制度 | 2025-10-29 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39091607 | 江苏浩欧博生物医药股份有限公司关于召开2025年第四次临时股东大会的通知 | 2025-10-29 | Chinese | ||
| 39091597 | 江苏浩欧博生物医药股份有限公司董事会提名委员会关于第三届董事会职工代表董事候选人任职资格的审查意见 | 2025-10-29 | Chinese | ||
| 39091592 | 江苏浩欧博生物医药股份有限公司会计师事务所选聘制度 | 2025-10-29 | Chinese | ||
| 39091581 | 江苏浩欧博生物医药股份有限公司累积投票制实施细则 | 2025-10-29 | Chinese | ||
| 39091575 | 江苏浩欧博生物医药股份有限公司独立董事工作细则 | 2025-10-29 | Chinese | ||
| 39091565 | 江苏浩欧博生物医药股份有限公司对外投资与资产处置管理制度 | 2025-10-29 | Chinese | ||
| 39091558 | 江苏浩欧博生物医药股份有限公司第三届监事会第二十二次会议决议公告 | 2025-10-29 | Chinese | ||
| 39091551 | 江苏浩欧博生物医药股份有限公司内部审计制度 | 2025-10-29 | Chinese | ||
| 39091541 | 江苏浩欧博生物医药股份有限公司信息披露制度 | 2025-10-29 | Chinese | ||
| 39091527 | 江苏浩欧博生物医药股份有限公司关联交易制度 | 2025-10-29 | Chinese | ||
| 39091517 | 江苏浩欧博生物医药股份有限公司关于取消监事会、修订《公司章程》并办理工商变更登记及修订、制定部分治理制度的公告 | 2025-10-29 | Chinese | ||
| 39091505 | 江苏浩欧博生物医药股份有限公司关于选举第三届董事会职工代表董事的公告 | 2025-10-29 | Chinese | ||
| 39091500 | 江苏浩欧博生物医药股份有限公司关于自愿披露签订合作框架协议暨风险提示公告 | 2025-10-21 | Chinese | ||
| 39091493 | 江苏浩欧博生物医药股份有限公司2025年第三次临时股东大会决议公告 | 2025-09-25 | Chinese | ||
| 39091488 | 国浩律师（上海）事务所关于江苏浩欧博生物医药股份有限公司2025年第三次临时股东大会的法律意见书 | 2025-09-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HOB BIOTECH GROUP CORP.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58562/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58562 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58562 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58562 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58562}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HOB BIOTECH GROUP CORP.,LTD. (id: 58562)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.